Abstract
Using a set of spectroscopic experiments, we investigated the binding of Cu2+ and Cu+ to a comprehensive series of nucleic acid‐related molecules, ranging from individual nucleobases to oligonucleotides up to six nucleotides in length. We demonstrate the selective binding of Cu+ to cytosine‐ and guanine‐containing oligonucleotides, as evidenced by their ability to compete with ferrozine for Cu+. The capacity to inhibit ascorbate oxidation, through effective sequestration catalytically active copper, increases with the number of cytosine residues in the oligonucleotides and is associated with the formation of a 1:1 Cu+‐oligonucleotide complex accompanied by a pronounced conformational change. In contrast, guanine‐rich oligonucleotides exhibit the opposite behavior: they form Cu+ G‐quadruplex structures that permit copper redox cycling. These findings highlight an unexpected binding of copper ions to nucleic acids in inert or redox‐active modes and thus expand its potential roles within cells through its direct interaction with DNA or RNA.
Keywords: copper complexes, cuprous ions, oligonucleotides, redox, spectroscopies
Using a comprehensive set of nucleic acid‐related molecules, from individual nucleobases to oligonucleotides, we demonstrate the selective binding of Cu+ to cytosine‐containing oligonucleotides. Contrary to guanine‐containing oligonucleotides, cytosine‐rich oligonucleotides form a Cu+‐complex with a clear near‐UV signature and are able to stop redox cycling of copper ions. These findings highlight an unexpected binding of Cu+ to nucleic acids in inert or redox‐active modes.

1. Introduction
Copper is an essential element to living organisms, involved in a multitude of physiological processes [1]. It acts primarily as a cofactor for numerous enzymes called cuproenzymes, enabling vital biochemical reactions [2, 3]. In cellular energy production, copper ions (Cu) are essential components of cytochrome c oxidase [1, 2]. To protect organisms against deleterious free radicals, copper–zinc superoxide dismutase is dependent on Cu [2], and in iron metabolism, Cu is crucial for iron absorption and hemoglobin synthesis [1]. With accessible redox potential, Cu2+ can be reduced to Cu+ biologically by physiological reductants, which gives it excellent electron transport properties, that are essential for those enzymatic reactions [4]. Although vital, excess of Cu can have harmful effects and become toxic, mainly due to its redox‐active nature, which allows it to catalyze the production of reactive oxygen species (ROS) [5]. ROS damage cell components and eventually cause cell death [1]. In Wilson’s genetic disease, accumulation of Cu is caused by a nonfunctional protein involved in Cu excretion [6]. In Alzheimer’s disease, Cu is involved in the production of oxidative damage to neurons [7], and high extracellular Cu concentrations are found in amyloid plaques [5]. In addition to ROS generation, Cu can be deleterious through its binding that can induce peptide/protein misfolding and promote aggregation [8, 9]. Due to its ambivalent nature, the interaction of Cu with DNA and other biomolecules has been extensively studied. However, for decades, the vast majority of these investigations focused exclusively on the stable Cu2+ and not Cu+ [10, 14]. To our best knowledge, there is very little scientific publications reporting behavior of Cu+ toward nucleic acid and DNA‐related molecules. This gap of the knowledge is very likely due to inherent difficulties to work with unstable Cu+. Indeed, Cu+ can be readily reoxidized to Cu2+ by dissolved dioxygen in aqueous solution, disproportionates to Cu2+ and Cu0, or precipitates into cuprous oxide (Cu2O). With the use of a glove box, it is now easier to overcome these limitations. However, since this instrumentation is not available in all laboratories, other methods have been developed. For example, a foundational study by Prütz [15], which drew on the work of Minchenkova and Ivanov [16], circumvented the stability issue by utilizing techniques such as pulsed and gamma radiolysis to generate Cu+ and observe its kinetic and structural effects on DNA and its models. In this present work, we will use a Cu+ stock solution stabilized by acetonitrile, and the challenges associated with its instability in solution will be overcome by first deoxygenating very carefully each solution with argon. With a limited set of techniques, mainly UV–vis, fluorescence, and circular dichroism (CD), and using minimum materials, this study aims to investigate Cu binding to nucleobases, nucleosides, nucleotides, and short‐length oligonucleotides (Figure 1) to better understand the interaction of Cu2+ and Cu+ with a comprehensive set of nucleic acid‐related molecules. The goal is to assess how a gradual increase in structural complexity and degree of organization influences molecules behavior toward Cu. Nucleobases, nucleosides, and nucleotides constitute the building blocks, while oligonucleotides allow to explore the emergence of collective behaviors related to sequence and secondary structure. The study is limited to oligonucleotides of up to six bases. Sequences of this size already cover a wide range of behaviors, from very short, loosely structured oligonucleotides to systems capable of adopting specific secondary conformations, notably G‐quadruplex‐type structures. The ability of Cu to bind to these molecules will be first assessed by a simple UV–vis experiment consisting of monitoring the depletion of ascorbate (Asc) in the presence of Cu and the tested molecules [17, 18]. We will then evaluate the specific affinity of nucleic acids for Cu+ or Cu2+ via competition experiments with two chelators (ferrozine and calcein, respectively). Finally, the effect of Cu addition on oligonucleotides will be assessed by CD.
FIGURE 1.

Schematic representation of studied molecules. Represented by a blue X, nucleobases (G for guanine, C for cytosine, A for adenine, and T for thymine); in the light gray dotted box, nucleosides; in the light gray dashed box, nucleotides; and in the black box, oligonucleotides X n with n = 2–6.
2. Results and Discussion
2.1. Oligonucleotides Synthesis and Purity
All oligonucleotides used in this study were synthesized and purified as described in the Supporting Information. Their LC–MS profiles are presented in Figure S1. The purity of the different oligonucleotides was determined by chromatographic peak integration and was estimated at 93% for A2, 86% for A3, 73% for A4, 88% for A5, 61% for A6, 89% for C2, 81% for C3, 87% for C5, 72% for C6, 96% for T2, 95% for T3, 87% for T4, 89% for T5, 93% for T6, 74% for G2, 82% for G3, 89% for G4, 86% for G5, and 86% for G6. LC–MS analysis could not be performed for C4 due to insufficient remaining sample quantity. The presence of peak shoulders may result from oligonucleotide organization phenomena, including secondary structure formation, favored under the low‐temperature conditions (30 °C) and high‐ionic strength of the mobile phases.
2.2. Ascorbate Consumption Experiments
The ability of nucleic acid and related molecules to prevent Asc oxidation by coordinating Cu+ or Cu2+ was investigated by UV–vis spectroscopy. Indeed, the presence of loosely bound Cu dramatically catalyzes the oxidation of Asc by dissolved dioxygen (Figure 2A). The kinetic rate of Asc consumption can be easily followed as the Asc shows a characteristic UV band at 265 nm (Figure 2B). In the absence of Cu, the consumption of Asc (initial concentration: 100 µM) is very slow, illustrated by a constant absorbance over time (Figure 2C, gray circles). The addition of Cu (Figure 2C, black squares) catalyzes the oxidation of Asc, as indicated by a rapid drop in absorbance (Figure 2B). If a strong Cu2+ chelator such as ethylene diamine‐tetra‐acetic acid (EDTA) (Figure 2C, orange down triangles) or a strong Cu+ chelator such as bicinchoninic acid (BCA) (Figure 2C, green up triangles) is added, Cu is tightly bound and Asc then ceases to be consumed, maintaining its constant absorbance at 265 nm [19]. The rapid and significant increase in absorbance at 265 nm after adding BCA is directly due to the fact that BCA itself absorbs strongly at 265 nm (Figure S2).
FIGURE 2.

(A) Schematic representation of ROS production by Cu in the presence of Asc. (B) Absorbance of Asc in the presence of Cu over time. (C) Normalized absorbance measured at λ = 265 nm over time. Kinetic of Asc consumption in the absence (gray circles) or in the presence of Cu added at 60 s (black squares) with subsequent addition at 120 s of Cu2+ chelator EDTA (orange down triangles) or Cu+ chelator BCA (green up triangles). Conditions: [HEPES] = 50 mM pH 7.4; [Asc] = 100 µM; [CuSO4] = 10 µM; and [BCA] = [EDTA] = 22 µM.
First, we tested the ability of nucleobases, nucleosides, and nucleotides to avoid the redox cycling of Cu. In the presence of these molecules, Asc is quickly consumed, except for adenine and guanine (Figure S3). Contrary to a former study, which showed that nucleosides and nucleotides, added in very large excess (up to 1000‐fold), are capable of inhibiting the Cu redox cycle [20], we demonstrate that, in our conditions, nucleosides and nucleotides have no effect on Asc consumption when they are added at a concentration of the same order of magnitude relative to Cu (Figure S4). It is interesting to note that among all these molecules tested, only the two purine bases of nucleic acids (guanine and adenine) are capable of slowing down Asc oxidation. Nitrogen N9 of purines bases, the most basic of N atoms, would therefore be the main atom involved in the coordination process of adenine and guanine with Cu [21, 22]. In nucleosides and nucleotides, the N9 is bound to the ribose and is no longer available, which could explain their lack of affinity with Cu.
We then tested the effect of oligonucleotide chain length (from 2–6 nucleotides) on Asc consumption (Figure 3A). For all measurements, oligonucleotide concentrations were normalized to the total nucleobase concentration. Therefore, the absorbance at 265 nm is not expected to scale directly with oligonucleotide length. First, thymine‐rich sequences have no effect on Asc consumption, clearly demonstrating that Cu has no particular affinity for thymine. In fact, carbonyl groups bind very weakly to d‐block transition divalent metal ions (M2+), which makes thymine less suitable for binding Cu2+ [12]. Cytosine‐rich oligonucleotides C n are the most effective to prevent Asc consumption, very likely due to the binding of cytosine to Cu2+ or Cu+ via nitrogen N3 [13, 14, 23]. It is also interesting to note that their ability to prevent Asc consumption increases with the number of bases in its sequence, suggesting an improved sequestration of Cu likely due to an intramolecular chelation by cytosine moieties (Figure 3B). Interestingly, for sequences rich in adenine, a similar trend seems to be observed as for cytosine‐rich sequence: the more bases a sequence contains, the higher its affinity appears to be, even though these oligonucleotide sequences are not as effective in stopping Asc consumption. The ability of oligonucleotides to fold into particular structure would then modulate the coordination of Cu. Indeed, the combination of multiple binding sites, the spatial proximity of these sites allowing the formation of stabilizing chelates, and the contribution of the phosphodiester backbone [24] make oligonucleotides better chelators than nucleosides or nucleotides alone [13]. For guanine‐rich molecules, the opposite phenomenon is observed: the shortest sequences are those that best stop Asc consumption. The ability of sufficiently guanine‐rich molecules to form secondary structures such as G‐quartets via hydrogen bonds could explain this trend. Indeed, according to the literature, guanine atoms of G n involved in the bond with Cu2+ are nitrogen N7 and oxygen O6 [14, 21, 22]. Thus, atoms normally involved in copper coordination would then be involved in the Hoogsteen bonds, to form the G‐quadruplex structures [25].
FIGURE 3.

(A) Normalized absorbance measured at λ = 265 nm over time. Kinetic of Asc consumption in the presence of Cu (added at 60 s) with subsequent addition of short‐length oligonucleotides X n (n = 2–6 bases) of adenine (top left), thymine (top right), guanine (bottom left), and cytosine (bottom right) (added at 120 s). Each bold line represents the average of three independent analyses. The width of the shaded band corresponds to the standard deviation around the mean. (B) Absolute value of the slopes of the kinetic monitoring of Asc consumption in UV–vis upon addition of Cu2+ and oligonucleotides as a function of the number of bases in the oligonucleotides X n . The slope is calculated between times 136 and 211 s, i.e., 6 points. Conditions: [HEPES] = 50 mM pH 7.4; [Asc] = 100 µM; [CuSO4] = 10 µM; and [oligonucleotides] × number of bases = 20 µM.
2.3. Competition Studies
To understand how some of the oligonucleotides are able to stop Asc consumption, competition studies were carried out with Cu2+ and Cu+ chelators. First, we harnessed the characteristics of calcein, a fluorescent molecule with chelating properties. Fluorescence emission from calcein is observed at a physiological pH of 7.4; however, the presence of various metal cations, such as Cu2+, results in pronounced quenching of its fluorescence, a phenomenon often exploited for metal ion detection [26]. The ability of a molecule to compete with calcein for Cu2+ is reflected by the recovery of the calcein fluorescence upon addition of this molecule. Therefore, the intensity of the fluorescence of calcein upon addition of a molecule shows the relative affinity of the added molecule for Cu2+. In Figure 4, different Cu2+ chelators with different affinities illustrate this phenomenon. EDTA has the highest affinity for Cu2+ (log K = 19.19) [27], followed by the amino‐terminal copper and nickel (ATCUN) binding motif peptide (log K ~ 14) [28] and finally glycine (log K = 8.28) [29]. EDTA, ATCUN motif, and glycine were employed as reference ligands to qualitatively compare Cu2+ binding affinity and competition behavior. Oligonucleotides X n have few effects on fluorescence, suggesting that they are not sufficiently affined with Cu2+ to sequester it from calcein. The findings from the competition assay indicate that the metal–ligand complex stabilities of the oligonucleotides are all relatively similar and that oligonucleotides have an affinity constant equal or lower than glycine. However, in contrast to Asc consumption, C2 was found to be more effective than C6 at recovering Cu2+ from calcein, while G6 similarly exhibited greater efficacy than G2. These observations raise the question of whether the affinity of oligonucleotides for Cu2+ influences the inhibition of Asc consumption. Given that glycine and oligonucleotides have comparable affinity constants, the experiment to stop Asc consumption was also performed in the presence of 20 µM glycine (Figure S5). It should be noted that glycine has no absorbance at 265 nm, so no increase in absorbance was observed when it was added at 120 s. In the presence of glycine, Cu catalyzes the oxidation of Asc with a consumption rate of 0.347 ± 0.058%/s (absolute value), which makes it comparable in terms of efficiency to short‐thymine sequences. Thus, despite the fact that oligonucleotides have a lower or comparable affinity than glycine for Cu2+, the impact on Asc consumption varies considerably, with oligonucleotides demonstrating greater inhibition of the redox cycle than glycine. It is therefore relevant to evaluate the influence of affinity for Cu+ on their ability to slow down Asc consumption.
FIGURE 4.

Normalized fluorescence of calcein in the absence or in the presence of Cu2+ (gray bars) and with addition of several compounds (colored bars). Conditions: [HEPES] = 50 mM pH 7.4; [calcein] = 1 μM; [CuSO4] = 0 or 1 μM; [oligonucleotides] × number of bases = 100 μM; [Cu2+ chelators] = 100 µM.
Competition experiments with ferrozine were then carried out. Ferrozine forms a 2:1 complex with Cu+ (log β 2 = 11.6), characterized by a band in the visible range at 470 nm [30]. In Figure 5, the effect of successive addition of the 6‐bases long oligonucleotides X6 to a solution of [Cu(Fz)2] is shown. Addition of C6 leads to a significant decrease in the 470 nm absorption band characteristic of the [Cu(Fz)2] complex, demonstrating its affinity for Cu+ (log K = 6.5), for calculation details refer to Experimental Details in the Supporting Information. The results indicate that G6 is also effective at sequestering Cu+ (log K = 5.9). However, its effectiveness appears to be lower than that of C6 but higher than that of A6 (log K = 5.2). T6, on the other hand, does not appear to have any particular affinity for Cu+.
FIGURE 5.

UV–vis spectra of successive additions of oligonucleotides A6 (top left), C6 (top right), T6 (bottom left), and G6 (bottom right) to a solution of [Cu(Fz)2]. Conditions: [HEPES] = 50 mM pH 7.4; [Fz] = 110 μM; and [Cu+] = 55 μM. The black curve corresponds to [Cu+] = 0 μM. The gray curve corresponds to the formation of the complex after adding Cu+. The colored curves correspond to the addition of X n from 3.8 µM up to 110 µM (bold curve). For details on the specific concentration increments, see Experimental Details in the Supporting Information.
The results are broadly in line with those obtained in Asc consumption assay. Oligonucleotides that slow down Asc oxidation are also able to bind Cu+ in ferrozine competition experiments. In the same way, most of the oligonucleotides with no effect on Asc consumption do not lower this absorption band of the Cu+‐ferrozine complex (Figure 6). Interestingly, G6 seems capable of binding to Cu+ and decreasing the absorption band but fails to slow down Asc consumption (Figures 5 and 6), suggesting the formation of a redox‐active complex between Cu and the oligonucleotide, thereby allowing the reduction and the oxidation of Cu during Asc consumption experiments.
FIGURE 6.

Oligonucleotides are represented by points whose coordinates are the respective values of the percentage of absorbance remaining in the [Cu(Fz)2] complex after adding 660 µM of nucleobases of X n at 470 nm and the slope of Asc consumption. Points in the green zone represent molecules capable of slowing down Asc consumption and recovering Cu+ to ferrozine. The red area represents molecules that are unable to stop or recover Cu. The orange areas are those with one of the two successful assays. The size of the icon represents the standard deviation by on three independent experiments. The limits of the different colored areas were defined arbitrarily for visualization purposes and do not correspond to strict physicochemical thresholds.
2.4. Titration
Nucleobases, nucleosides, nucleotides, and oligonucleotides X2 and X6 were titrated with Cu2+ and Cu+ solutions. The UV spectra of all molecules are included in the Supporting Information (Figure S6 for adenine family, Figure S7 for thymine family, Figure S8 for guanine family, and Figure S9 for cytosine family) with the exception of T6, A6, G6, and C6, which are presented in Figure 7. As expected, titration of the molecules with Cu2+ resulted in a uniform increase in absorbance intensity, with no significant spectral changes observed, suggesting weak or nonspecific interactions. The only molecules that behaves differently are the nucleobases adenine and guanine, which shows a slight bathochromic shift upon Cu2+ addition (likely due to availability of atom N9 which is no longer available in nucleosides, nucleotides, or oligonucleotides, as involved in glycosidic bond to the ribose). The results of the Cu2+ titration with oligonucleotides are consistent with the results previously obtained using calcein competition. Similarly, in the presence of Cu+, a change in the UV spectrum of nucleobase adenine is observed, indicating a strong interaction between the base and the metal cation (Figure S6). The titration of the other molecules, including T6, A6, and G6 with Cu+, resulted also in a small uniform increase in absorbance intensity without spectral changes, suggesting for the oligonucleotides T6 and A6, an absence of a specific interaction, and for G6, a nonperturbing binding that does not alter the structure and the electronic transitions of the molecule. However, titration of C6 with Cu+ led to the emergence of a new large absorption band around 315 nm, strongly indicating the formation of a unique type of Cu+ complex, likely with a 1:1 stoichiometry (Figure S10). It is worth noting that the C6 affinity for Cu+ determined by direct titration (log K = 6.3, Figure S10) is in good agreement with affinity obtained from ferrozine competition experiments (log K = 6.5, Figure 5). This absorption band can also be observed in the spectrum of Asc consumption experiment in the presence of Cu and C6 (Figure S11). The presence of this band suggests that the ability of C6 to halt the consumption of Asc comes from its capacity to chelate Cu+ and form a complex stable enough to prevent the reoxidation of Cu+ to Cu2+ in the presence of oxygen.
FIGURE 7.

UV–vis spectra of oligonucleotides T6; A6; G6; and C6 (from left to right, gray) and successive additions of Cu2+ (scale on right axis, red) and Cu+ (scale on left axis, blue). Conditions: [HEPES] = 50 mM pH 7.4; [T6] = 6 µM; [A6] = 3.5 µM; [G6] = 6 µM; [C6] = 8 µM; [Cu2+] = 0–20 µM; and [Cu+] = 0–20 µM.
2.5. Circular Dichroism
To complement the titration analyses, CD experiments were then carried out to compare the signal of oligonucleotides alone and in the presence of both redox states of Cu at stoichiometry 1:1. The objective is to investigate the structure of oligonucleotides X2 and X6 in the presence of Cu+ and Cu2+ in order to address the possible change in their structures, which would not have been observed in the UV–vis experiments. A range of information can be extracted from these results. First, it has been demonstrated that in the presence of Cu2+ and Cu+, the CD spectra of thymine‐ and adenine‐rich molecules are identical to the spectra of the molecules alone (Figure S12). The presence of Cu therefore does not alter the overall structure of the oligonucleotides. These results are consistent with the results of previous experiments, allowing us to deduce that A2, A6, T2, and T6 have little affinity and do not form complexes with Cu+, as mentioned in a former study [15]. Regarding oligonucleotides composed of cytosine, their CD spectra are very similar to their spectrum in the presence of Cu2+. However, in the presence of Cu+, dramatically changes in the CD spectrum are observed.
For C2 (Figure S13), the band at 280 nm is replaced by a positive band at 250 nm. This indicates that their three‐dimensional structure has been modified in the presence of Cu+. For C6 (Figure 8), the positive band at 280 nm disappears, giving way to a negative band at 320 nm. With increasing amounts of Cu+, the spectral changes were progressively observed until reaching a plateau at a 1:1 Cu+/C6 ratio, confirming the formation of a 1:1 complex with Cu+ (Figure S14). Figure S15 shows control experiments of the UV and CD spectra of C6 under an argon atmosphere with acetonitrile addition, clearly illustrating that the changes observed before are only due to Cu+ and not to the low amount of acetonitrile added with Cu+ addition. The results of these various analyses carried out on cytosine‐rich molecules suggest that Cu2+ prefers to remain solvated in biological aqueous media (hydration enthalpy = −2100 kJ/mol), whereas an interaction between Cu+, which is less hydrated (hydration enthalpy = −593 kJ/mol), and cytosine occurs, as evidenced by the modification of the CD spectra [31]. We suggest that the coordination site of the Cu+‐C6 complex consists of cytosine‐Cu+‐cytosine, where Cu+ is bound to the nitrogen atoms N3 from two cytosines, analogous to the Cu+–i‐motif DNA structure and to Ag+ interacting with cytosines [31, 32]. The CD spectra of G2 alone and in the presence of Cu2+ are very similar (Figure S13). However, a small positive CD signal is observed near 240 nm, only in the presence of Cu+, which could be interpreted as an interaction between the two species. Regarding G6, its CD spectrum is characterized by a positive peak at 260 nm and a negative peak at 240 nm. This dichroic signature corresponds to the presence of parallel G‐quadruplexes [33]. This result supports our hypothesis regarding the ability of G n oligonucleotides to form G‐quadruplexes in HEPES buffer. These characteristic peaks are also observed in the presence of Cu. With Cu2+, the CD spectra are similar. However, when Cu+ is added, the positive peak at 260 nm is less intense. This observation could be explained by the fact that G6 and Cu+ interact without modifying the G‐quadruplex structure adopted by G6, but by destabilizing it, hence the decrease in intensity. Thus, G6 may rearrange itself specifically to bind Cu+ while retaining its G‐quadruplex identity, forming a complex. To support this hypothesis, CD analysis of the G5 oligonucleotide, which is also capable of forming a G‐quadruplex structure, was performed in the presence of different concentrations of Cu+ (Fig. S16). As the amount of Cu+ increases, the intensity of the G‐quadruplex decreases. The ability of G6 to retrieve Cu+ from ferrozine but not to prevent the oxidation of Asc strongly suggests that this complex allows the redox change by binding the different oxidation states of Cu. This interpretation is supported by recent papers of Sahu et al. [34, 35] that show that Cu+ can induce the formation of highly stable G‐quartets from guanosine, without K+ or Na+ and that these G‐quartets selfassemble to form supramolecular polymers. Furthermore, their results suggest that this supramolecular assembly is labile and allows Cu+ to oxidize to Cu2+ without immediately destroying the structure but which can reversibly dismantle it in response to this oxidation.
FIGURE 8.

CD spectra of oligonucleotides C6 (left) and G6 (right) in the absence and in the presence of Cu+ and Cu2+ at stoichiometry 1:1. Conditions: [HEPES] = 50 mM pH 7.4; [C6] = [Cu+] = [Cu2+] = 8 µM; and [G6] = [Cu+] = [Cu2+] = 5 µM.
These changes in CD and UV spectra effectively support our results that cytosine‐rich molecules have an affinity for Cu+ which will cause a structural change in the oligonucleotides, while guanine‐rich molecules can interact with Cu+ by keeping the G‐quadruplex structures.
3. Conclusion
In this study, the interaction of DNA‐related molecules with Cu was investigated using simple spectroscopic methods with a focus on small oligonucleotide. We demonstrate that oligonucleotides composed of cytosine or guanine have a strong affinity for Cu+. Cytosine‐rich oligonucleotides appear to form an inert complex with Cu+, while guanine‐rich oligonucleotides, structured in the form of G‐quadruplexes, enable the redox cycle of Cu. The implications of this research are important for better understanding the interaction of DNA/RNA with Cu, which is present in the body. The uptake of Cu inside cell is mediated by CTR1 protein [36]. Once inside the cell, free Cu+ is immediately sequestered by chaperones. Nevertheless, each human cell contains approximately two meters of DNA coiled and compacted within its nucleus [37] and about 6 pg and 20 pg of DNA and RNA materials, respectively [38]. Based on these numbers, concentrations of nucleobases within nucleic acid polymers are about 50 mM both in the cytoplasm and nucleus. This enormous concentration and a vast contact surface provide multiple potential sites for Cu+ binding. The presence of this element inside the cell, even at low concentrations and sequestered, can create an environment conducive to unexpected interactions with nucleic acids, which would compete with metallochaperones given their overwhelming concentration. Furthermore, the ends of human chromosomes, rich in guanine repeats, can spontaneously form G‐quadruplexes, which could regulate telomerase activity and act as a protective cap at the end of chromosomes, preventing telomere DNA from degrading [39]. However, we have shown that Cu+ can interact with these structures, and thus, Cu+ could modulate the stability of telomeric G‐quadruplexes. Moreover, with the growing interest in using nucleic acids‐based therapeutics, it is critical to expand our understanding of their chelating properties. This knowledge is essential for integrating them into potential treatments linked to copper imbalance, such as in Alzheimer’s and Wilson’s disease.
Funding
This study was supported by Conseil National de la Recherche Scientifique (CNRS) via MITI programs (Metallo‐Mix call) and FrenchBIC.
Conflicts of Interest
The authors declare no conflicts of interest.
Supporting information
Supplementary Material
Acknowledgments
This project has received financial support from CNRS through the MITI interdisciplinary programs (Metallo‐Mix call). We acknowledge the FrenchBIC for the mobility grant allocated to Mathilde Brachet. We thank Brune Vialet for oligonucleotides synthesis and thank Alice Eplenier and Eric Largy for fruitful discussions. We also thank Sandy Al Bardawil and Kenza Tamsamani for their valuable assistance with the additional experiments performed in response to the reviewers’ comments.
Data Availability Statement
The data that supports the findings of this study are available in the supplementary material of this article.
References
- 1. Binesh A. and Venkatachalam K., “Copper in Human Health and Disease: A Comprehensive Review,” Journal of Biochemical and Molecular Toxicology 38 (2024): e70052. [DOI] [PubMed] [Google Scholar]
- 2. Ruiz L. M., Libedinsky A., and Elorza A. A., “Role of Copper on Mitochondrial Function and Metabolism,” Frontiers in Molecular Biosciences 8 (2021): 711227. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Kim B. E., Nevitt T., and Thiele D. J., “Mechanisms for Copper Acquisition, Distribution and Regulation,” Nature Chemical Biology 4, no. 3 (2008): 176–185. [DOI] [PubMed] [Google Scholar]
- 4. Ackerman C. M. and Chang C. J., “Copper Signaling in the Brain and Beyond,” Journal of Biological Chemistry 293, no. 13 (2018): 4628–4635. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Smith D. G., Cappai R., and Barnham K. J., “The Redox Chemistry of the Alzheimer’s Disease Amyloid β Peptide,” Biochimica et Biophysica Acta (BBA) – Biomembranes 8 (2007): 1976–1990. [DOI] [PubMed] [Google Scholar]
- 6. Petruzzelli R., Catalano F., Crispino R., et al., “Prion Protein Promotes Copper Toxicity in Wilson Disease,” Nature Communications 16 (2025): 1468. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Brewer G., “Copper in Medicine,” Current Opinion in Chemical Biology 7, no. 2 (2003): 207–212. [DOI] [PubMed] [Google Scholar]
- 8. Syme C. D., Nadal R. C., Rigby S. E. J., and Viles J. H., “Copper Binding to the Amyloid‐β (aβ) Peptide Associated With Alzheimer’s Disease,” Journal of Biological Chemistry 279 (2004): 18169–18177. [DOI] [PubMed] [Google Scholar]
- 9. Alies B., Hureau C., and Faller P., “The Role of Metal Ions in Amyloid Formation: General Principles From Model Peptides,” Metallomics 5 (2013): 183–192. [DOI] [PubMed] [Google Scholar]
- 10. Coates J. H., Jordan D. O., and Srivastava V. K., “The Binding of Copper(II) Ions to DNA,” Biochemical and Biophysical Research Communications 20 (1965): 611–615. [DOI] [PubMed] [Google Scholar]
- 11. Sissoëff I., Grisvard J., and Guillé E., “Studies on Metal Ions‐DNA Interactions: Specific Behaviour of Reiterative DNA Sequences,” Progress in Biophysics and Molecular Biology 31 (1978): 165–199. [DOI] [PubMed] [Google Scholar]
- 12. Sigel R. K. O. and Sigel H., Comprehensive Inorganic Chemistry II, (Elsevier, 2013), 623–660. [Google Scholar]
- 13. Sigel R. K. O. and Sigel H., “A Stability Concept for Metal Ion Coordination to Single‐Stranded Nucleic Acids and Affinities of Individual Sites,” Accounts of Chemical Research 43 (2010): 974–984. [DOI] [PubMed] [Google Scholar]
- 14. Erxleben A., “Interactions of Copper Complexes With Nucleic Acids,” Coordination Chemistry Reviews 360 (2018): 92–121. [Google Scholar]
- 15. Prütz W. A., Butler J., and Land E. J., “Interaction of Copper(I) With Nucleic Acids,” International Journal of Radiation Biology 58 (1990): 215–234. [DOI] [PubMed] [Google Scholar]
- 16. Minchenkova L. E. and Ivanov V. I., “Influence of Reductants Upon Optical Characteristics of the DNA–Cu2+ Complex,” Biopolymers 5 (1967): 615–625. [DOI] [PubMed] [Google Scholar]
- 17. Conte‐Daban A., Beyler M., Tripier R., and Hureau C., “Kinetics Are Crucial When Targeting Copper Ions to Fight Alzheimer’s Disease: An Illustration With Azamacrocyclic Ligands,” Chemistry – A European Journal 24 (2018): 8447–8452. [DOI] [PubMed] [Google Scholar]
- 18. Malikidogo K. P., Drommi M., Atrián‐Blasco E., et al., “Ability of Azathiacyclen Ligands to Stop Cu(aβ)‐Induced Production of Reactive Oxygen Species: [3N1S] Is the Right Donor Set,” Chemistry – A European Journal 29 (2023): e202203667. [DOI] [PubMed] [Google Scholar]
- 19. Bagrel M., Hureau C., and Falcone E., “A Cocktail of Two Chelators Is Not Better Than One Ligand in Excess to Halt Cu, Zn‐(Amyloid‐β)‐Induced ROS Production in the Context of Alzheimer’s Disease,” Inorganic Chemistry 64 (2025): 20875–20880. [DOI] [PubMed] [Google Scholar]
- 20. Frieden E. and Alles J., “Subtle Interactions of Cupric Ion With Nucleic Acid and Components,” Journal of Biological Chemistry 230 (1958): 797–804. [PubMed] [Google Scholar]
- 21. Choquesillo‐Lazarte D., Brandi‐Blanco M. D. P., García‐Santos I., González‐Pérez J. M., Castiñeiras A., and Niclós‐Gutiérrez J., “Interligand Interactions Involved in the Molecular Recognition Between Copper(II) Complexes and Adenine or Related Purines,” Coordination Chemistry Reviews 252 (2008): 1241–1256. [Google Scholar]
- 22. Lippert B., “Multiplicity of Metal Ion Binding Patterns to Nucleobases,” Coordination Chemistry Reviews 202 (2000): 487–516. [Google Scholar]
- 23. Bregier‐Jarzebowska R., Gasowska A., and Lomozik L., “Complexes of Cu(II) Ions and Noncovalent Interactions in Systems With L‐Aspartic Acid and Cytidine‐5′‐Monophosphate,” Bioinorganic Chemistry and Applications 2008 (2008): 253971. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Eichhorn G. L., Clark P., and Becker E. D., “Interactions of Metal Ions With Polynucleotides and Related Compounds. VII. The Binding of Copper(II) to Nucleosides, Nucleotides, and Deoxyribonucleic Acids*,” Biochemistry 5 (1966): 245–253. [DOI] [PubMed] [Google Scholar]
- 25. Bochman M. L., Paeschke K., and Zakian V. A., “DNA Secondary Structures: Stability and Function of G‐Quadruplex Structures,” Nature Reviews Genetics 13 (2012): 770–780. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Helsel M. E., White E. J., Razvi S. Z. A., Alies B., and Franz K. J., “Chemical and Functional Properties of Metal Chelators that Mobilize Copper to Elicit Fungal Killing of Cryptococcus Neoformans,” Metallomics 9 (2017): 69–81. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. Baumann E. W., “Investigation of Copper(II) Chelates of EDTA and DTPA With Cupric‐Selective Electrodes,” Journal of Inorganic and Nuclear Chemistry 36 (1974): 1827–1832. [Google Scholar]
- 28. Noormägi A., Golubeva T., Berntsson E., Wärmländer S. K. T. S., Tõugu V., and Palumaa P., “Direct Competition of ATCUN Peptides With Human Serum Albumin for Copper(II) Ions Determined by LC‐ICP MS,” ACS Omega 8 (2023): 33912–33919. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Hamada Y. Z., Makoni N., and Hamada H., “Cu2+ Complexes With the Simplest Amino Acid Glycine (Gly),” Journal of Nanomedicine Research 5 (2017): 00123. [Google Scholar]
- 30. Alies B., Badei B., Faller P., and Hureau C., “Reevaluation of Copper(I) Affinity for Amyloid‐β Peptides by Competition With Ferrozine—An Unusual Copper(I) Indicator,” Chemistry – A European Journal 18 (2012): 1161–1167. [DOI] [PubMed] [Google Scholar]
- 31. Abdelhamid M. A., Fábián L., MacDonald C. J., Cheesman M. R., Gates A. J., and Waller Z. A., “Redox‐Dependent Control of i‐Motif DNA Structure Using Copper Cations,” Nucleic Acids Research 46 (2018): 5886–5893. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32. Alies B., Ouelhazi M. A., Noireau A., Gaudin K., and Barthélémy P., “Silver Ions Detection via Nucleolipids Self‐Assembly,” Analytical Chemistry 91 (2019): 1692–1695. [DOI] [PubMed] [Google Scholar]
- 33. Kypr J., Kejnovska I., Renciuk D., and Vorlickova M., “Circular Dichroism and Conformational Polymorphism of DNA,” Nucleic Acids Research 37 (2009): 1713–1725. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34. Sahu N., Guchhait C., Mohanta I., Suriyaa V., and Adhikari B., “Cu(I)‐Induced G‐Quartets: Robust Supramolecular Polymers Exhibiting Heating‐Induced Aqueous Phase Transitions Into Gel or Precipitate,” Angewandte Chemie International Edition 64 (2025): e202417508. [DOI] [PubMed] [Google Scholar]
- 35. Sahu N., Rath S., Bal P. P., Suriyaa V., Guchhait C., and Adhikari B., “Cu2+‐Induced Gelation of Guanosine: Supramolecular Transition From G2·(Cu2+)2 to G·Cu+ Assemblies in Gel,” Chemistry – An Asian Journal 21 (2026): e00870. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36. Lutsenko S., Roy S., and Tsvetkov P., “Mammalian Copper Homeostasis: Physiological Roles and Molecular Mechanisms,” Physiological Reviews 105 (2025): 441–491. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37. Alberts B., Johnson A., Lewis J., Raff M., Roberts K., and Walter P., Molecular Biology of the Cell, 4th ed. (Garland Science, 2002). [Google Scholar]
- 38. Milo R., Jorgensen P., Moran U., Weber G., and Springer M., “BioNumbers—the Database of Key Numbers in Molecular and Cell Biology,” Nucleic Acids Research 38 (2010): D750–D753. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39. Bryan T. M., “G‐Quadruplexes at Telomeres: Friend or Foe?,” Molecules 25 (2020): 3686. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Supplementary Material
Data Availability Statement
The data that supports the findings of this study are available in the supplementary material of this article.
